Close Menu


Bioo licensed technology to reduce ligation bias in NGS and has incorporated it into its RNA-seq library prep kit.

Sales for its human health segment increased a fraction of 1 percent, while the environmental health segment climbed 6 percent.

The Suzhou, China-based laboratory will focus on neonatal testing and infectious diseases, with the potential to expand into cancer testing. 

The companies last month agreed to a dismissal of their claims and counterclaims with prejudice, meaning they cannot bring further suit based on the claims.

Not everyone benefits from PD-1 targeting drugs, and OncoSec is working with UCLA and PerkinElmer to see if they can identify the non-responders.

OncoSec Medical is working with UCLA, using PerkinElmer technology, to develop molecular biomarkers to pick out anti-PD-1 non-responders who might benefit from added cytokine therapy.

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market Thursday that its third quarter revenues increased 4 percent year over year.

NEW YORK (GenomeWeb) – A federal court has issued a mixed decision in the ongoing patent dispute between PerkinElmer and Agilent Technologies regarding their mass spectrometry technologies and a licensing agreement.

NEW YORK (GenomeWeb) – Privately-held UK-based informatics solutions provider Dotmatics is planning to expand its business in the North American market and has hired Rusty Irving to head its efforts on that front.


NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.